Osteoarthritis Ankle
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
DT MedTechNetherlands - s-Hertogenbosch
1 programHintermann Series H3 Total Ankle Replacement SystemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
DT MedTechHintermann Series H3 Total Ankle Replacement System
Anika TherapeuticsMonovisc
Clinical Trials (2)
Total enrollment: 257 patients across 2 trials
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
Start: Feb 2022Est. completion: Apr 2029232 patients
N/ARecruiting
MONOVISC for Ankle Joint Pain Relief Due to Osteoarthritis
Start: Dec 2019Est. completion: Mar 202125 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 257 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.